Browsing by Author "El Sony A."

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    Global Asthma Network survey suggests more national asthma strategies could reduce burden of asthma
    (Elsevier Doyma, 2017) Asher I.; Haahtela T.; Selroos O.; Ellwood P.; Ellwood E.; Billo N.E.; Bissell K.; Chiang C.-Y.; El Sony A.; García-Marcos L.; Mallol J.; Marks G.B.; Pearce N.; Strachan D.; Priftanji A.; Benhabylès B.; Boukari R.; Castracane F.A.; Gómez M.; Salmun N.; Baghdasaryan A.; Burgess S.; Mattes J.; Tai A.; Haidinger G.; Riedler J.; Shpakou A.; Weyler J.; Gninafon M.; Aguirre de Abruzzese J.; Domuz S.; Brandão H.V.; Camargos P.A.M.; de Britto M.; Fischer G.B.; Kuschnir F.C.; Menezes A.M.; Porto Neto A.C.; Rosário N.; Solé D.; Wandalsen N.F.; Mustakov T.B.; Birba E.; Mbatchou Ngahane B.H.; Pefura Yone E.W.; Rennie D.C.; To T.; Standring P.; Calvo Gil M.A.; Chen Y.-Z.; Kan X.; Lin Y.; Garcia E.; Niederbacher J.; Ordoñez G.A.; Kabengele Obel B.; Soto-Quirós M.E.; Banac S.; Yiallouros P.; Lochte L.; Barba S.; Cooper P.; El Falaki M.; Mokhtar A.; Figueroa Colorado M.; Berihu A.; Weihe P.; Lal V.A.; Mäkelä M.; Annesi-Maesano I.; Charpin D.; Raherison C.; Gotua M.; von Mutius E.; Addo-Yobo E.O.; Clement N.F.; Gratziou C.; Tsanakas J.; Akpinar-Elci M.; Lai C.K.W.; Novák Z.; Awasthi S.; Ilangho R.; Maitra A.; Mukherjee M.; Pai U.A.; Pherwani A.V.; Reddy B.K.; Sabir M.; Sharma S.K.; Singh V.; Singh M.; Sukumaran T.U.; Varkki S.; Kartasasmita C.B.; Cheraghi M.; Karimi M.; Masjedi M.-R.; Manning P.; Shohat T.; Bonini S.; Forastiere F.; La Grutta S.; Petronio M.G.; Piffer S.; Kahwa E.; Odajima H.; Yoshihara S.; Abu-Ekteish F.; Al Omari O.; Amukoye E.I.; Esamai F.O.; Hong S.-J.; Neziri-Ahmetaj L.; Al-Momen J.A.; Svabe V.; Shenkada M.; Vlaski E.; Mortimer K.; de Bruyne J.; Toloba Y.; Montefort S.; Del-Río-navarro B.E.; García-Almaráz R.; González-Díaz S.N.; Hernández-Colín D.D.; Jiménez González C.A.; Mérida-Palacio J.V.; Brunekreef B.; Currie S.; Douwes J.; Graham D.; Hancox R.; Moyes C.; Pattemore P.; Cordero Rizo M.Z.; Erhabor G.E.; Falade A.; Garba Ilah B.; Hammangabdo A.; Onyia N.; Pulu M.; Nystad W.; Al-Rawas O.; Yusuf M.O.; Watson B.M.; El Sharif N.; Cukier G.; Checkley W.; Chiarella P.; Pagcatipunan R.; Lis G.; Morais-Almeida M.; Deleanu D.; Kamaltynova E.; Kondiurina E.G.; Esera-Tulifau L.; Al-Ghamdi B.R.; Yousef A.; Toure N.O.; Hadnadjev M.; Višnjevac D.; Zivkovic Z.; Fadlu-Deen G.; Goh D.Y.T.; Masekala R.; Voyi K.; Zar H.J.; Arnedo-Pena A.; Busquets R.M.; Carvajal-Urueña I.; González Díaz C.; Korta Murua J.; López-Silvarrey Varela A.; Luna-Paredes C.; Morales-Suárez-varela M.; Praena-Crespo M.; Rabadán-Asensio A.; Wärnberg J.; Gunasekera K.D.; Kudagammana S.T.; Hassanain S.; Mohammad Y.; Guo Y.L.; Huang J.-L.; Laoaraya M.; Phumethum S.; Teeratakulpisarn J.; Vichyanond P.; Anderson S.; Tidjani O.; Iosefa T.; Aho G.; Dookeeram D.; Hamzaoui A.; Yorgancioğlu A.; Ituaso-Conway N.; Worodria W.; Fedortsiv O.; Mahboub B.; Mansur A.H.; Doshi R.P.; Redding G.J.; Yeatts K.; Valentin-Rostan M.; Harrison G.; Le L.T.T.; Wa Somwe S.; Manangazira P.
    Background Several countries or regions within countries have an effective national asthma strategy resulting in a reduction of the large burden of asthma to individuals and society. There has been no systematic appraisal of the extent of national asthma strategies in the world. Methods The Global Asthma Network (GAN) undertook an email survey of 276 Principal Investigators of GAN centres in 120 countries, in 2013–2014. One of the questions was: “Has a national asthma strategy been developed in your country for the next five years? For children? For adults?”. Results Investigators in 112 (93.3%) countries answered this question. Of these, 26 (23.2%) reported having a national asthma strategy for children and 24 (21.4%) for adults; 22 (19.6%) countries had a strategy for both children and adults; 28 (25%) had a strategy for at least one age group. In countries with a high prevalence of current wheeze, strategies were significantly more common than in low prevalence countries (11/13 (85%) and 7/31 (22.6%) respectively, p < 0.001). Interpretation In 25% countries a national asthma strategy was reported. A large reduction in the global burden of asthma could be potentially achieved if more countries had an effective asthma strategy. © 2017 SEICAP
  • No Thumbnail Available
    Item
    Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
    (International Union Against Tuberculosis and Lung Disease, 2022) Stolbrink M.; Chinouya M.J.; Jayasooriya S.; Nightingale R.; Evans-Hill L.; Allan K.; Allen H.; Balen J.; Beacon T.; Bissell K.; Chakaya J.; Chiang C-Y.; Cohen M.; Devereux G.; El Sony A.; Halpin D.M.G.; Hurst J.R.; Kiprop C.; Lawson A.; Macé C.; Makhanu A.; Makokha P.; Masekela R.; Meme H.; Khoo E.M.; Nantanda R.; Pasternak S.; Perrin C.; Reddel H.; Rylance S.; Schweikert P.; Were C.; Williams S.; Winders T.; Yorgancioglu A.; Marks G.B.; Mortimer K.
    BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low- and middle-income countries (LMICs), causing avoidable morbidity and mortality. The International Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this topic in February 2022. METHODS : Focused group discussions were informed by literature and presentations summarising experiences of obtaining inhaled medicines in LMICs. The virtual meeting was moderated using a topic guide around barriers and solutions to improve access. The thematic framework approach was used for analysis. RESULT S : A total of 58 key stakeholders, including patients, healthcare practitioners, members of national and international organisations, industry and WHO representatives attended the meeting. There were 20 pre-meeting material submissions. The main barriers identified were 1) low awareness of CRDs; 2) limited data on CRD burden and treatments in LMICs; 3) ineffective procurement and distribution networks; and 4) poor communication of the needs of people with CRDs. Solutions discussed were 1) generation of data to inform policy and practice; 2) capacity building; 3) improved procurement mechanisms; 4) strengthened advocacy practices; and 5) a World Health Assembly Resolution. CONC L U S ION: There are opportunities to achieve improved access to affordable, quality-assured inhaled medicines in LMICs through coordinated, multi-stakeholder, collaborative efforts. © 2022 International Union against Tubercul. and Lung Dis.. All rights reserved.